as part of the national heart , lung , and blood institute multicenter thrombolysis in myocardial infarction trial , the time to peak plasma creatine kinase ( ck ) activity as a marker of reperfusion in 272 patients with validated acute myocardial infarction was analyzed .
C0018787
heart
C0027051
myocardial infarction